GPA
Garrison Point Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Hold |
10,576
| – | – | 0.1% | 158 |
|
|
2025
Q1 | $176K | Hold |
10,576
| – | – | 0.09% | 159 |
|
|
2024
Q4 | $194K | Hold |
10,576
| – | – | 0.09% | 159 |
|
|
2024
Q3 | $163K | Buy |
+10,576
| New | +$163K | 0.1% | 144 |
|
|
2024
Q2 | – | Sell |
-10,020
| Closed | -$185K | – | 144 |
|
|
2024
Q1 | $185K | Hold |
10,020
| – | – | 0.12% | 148 |
|
|
2023
Q4 | $314K | Hold |
10,020
| – | – | 0.22% | 112 |
|
|
2023
Q3 | $209K | Hold |
10,020
| – | – | 0.16% | 139 |
|
|
2023
Q2 | $240K | Sell |
10,020
-250
| -2% | -$5.99K | 0.17% | 137 |
|
|
2023
Q1 | $193K | Hold |
10,270
| – | – | 0.15% | 154 |
|
|
2022
Q4 | $163K | Hold |
10,270
| – | – | 0.13% | 139 |
|
|
2022
Q3 | $168K | Hold |
10,270
| – | – | 0.15% | 137 |
|
|
2022
Q2 | $145K | Buy |
10,270
+50
| +0.5% | +$706 | 0.12% | 146 |
|
|
2022
Q1 | $248K | Hold |
10,220
| – | – | 0.17% | 134 |
|
|
2021
Q4 | $239K | Buy |
+10,220
| New | +$239K | 0.16% | 141 |
|
|
2021
Q1 | – | Sell |
-4,525
| Closed | -$242K | – | 142 |
|
|
2020
Q4 | $242K | Buy |
+4,525
| New | +$242K | 0.19% | 123 |
|
|
2020
Q3 | – | Sell |
-4,525
| Closed | -$219K | – | 130 |
|
|
2020
Q2 | $219K | Sell |
4,525
-250
| -5% | -$12.1K | 0.22% | 116 |
|
|
2020
Q1 | $202K | Sell |
4,775
-1,352
| -22% | -$57.2K | 0.25% | 106 |
|
|
2019
Q4 | $262K | Hold |
6,127
| – | – | 0.24% | 109 |
|
|
2019
Q3 | $221K | Buy |
+6,127
| New | +$221K | 0.22% | 115 |
|